» Articles » PMID: 31130953

Human Gut-Associated Natural Killer Cells in Health and Disease

Overview
Journal Front Immunol
Date 2019 May 28
PMID 31130953
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

It is well established that natural killer (NK) cells are involved in both innate and adaptive immunity. Indeed, they can recognize molecules induced at the cell surface by stress signals and virus infections. The functions of NK cells in the gut are much more complex. Gut NK cells are not precisely organized in lymphoid aggregates but rather scattered in the epithelium or in the stroma, where they come in contact with a multitude of antigens derived from commensal or pathogenic microorganisms in addition to components of microbiota. Furthermore, NK cells in the bowel interact with several cell types, including epithelial cells, fibroblasts, macrophages, dendritic cells, and T lymphocytes, and contribute to the maintenance of immune homeostasis and development of efficient immune responses. NK cells have a key role in the response to intestinal bacterial infections, primarily through production of IFNγ, which can stimulate recruitment of additional NK cells from peripheral blood leading to amplification of the anti-bacterial immune response. Additionally, NK cells can have a role in the pathogenesis of gut autoimmune inflammatory bowel diseases (IBDs), such as Crohn's Disease and Ulcerative Colitis. These diseases are considered relevant to the generation of gastrointestinal malignancies. Indeed, the role of gut-associated NK cells in the immune response to bowel cancers is known. Thus, in the gut immune system, NK cells play a dual role, participating in both physiological and pathogenic processes. In this review, we will analyze the known functions of NK cells in the gut mucosa both in health and disease, focusing on the cross-talk among bowel microenvironment, epithelial barrier integrity, microbiota, and NK cells.

Citing Articles

Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases.

Calvez V, Puca P, Di Vincenzo F, Del Gaudio A, Bartocci B, Murgiano M Biomedicines. 2025; 13(2).

PMID: 40002718 PMC: 11853239. DOI: 10.3390/biomedicines13020305.


Dysbiosis-NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes.

Fanijavadi S, Jensen L Int J Mol Sci. 2025; 26(2).

PMID: 39859442 PMC: 11765696. DOI: 10.3390/ijms26020730.


Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis.

Hu Y, Tang J, Yu D, Su S, Fang J, Xia L BMC Gastroenterol. 2025; 25(1):23.

PMID: 39833691 PMC: 11748810. DOI: 10.1186/s12876-025-03603-w.


Epstein-Barr Virus BRRF1 Induces Butyrophilin 2A1 in Nasopharyngeal Carcinoma NPC43 Cells via the IL-22/JAK3-STAT3 Pathway.

Liu Y, Lui K, Ye Z, Chen L, Cheung A Int J Mol Sci. 2025; 25(24.

PMID: 39769218 PMC: 11677325. DOI: 10.3390/ijms252413452.


Relationship between the risk of intestinal mucosal Epstein-Barr virus and/or cytomegalovirus infection and peripheral blood NK cells numbers in patients with ulcerative colitis: a cross-sectional study in Chinese population.

Tian Y, Dai J, Yang Y, Guo X, Wang W, Li F Front Microbiol. 2024; 15:1498483.

PMID: 39697654 PMC: 11652489. DOI: 10.3389/fmicb.2024.1498483.


References
1.
Madsen K, Malfair D, Gray D, Doyle J, Jewell L, Fedorak R . Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999; 5(4):262-70. DOI: 10.1097/00054725-199911000-00004. View

2.
Daig R, Rogler G, Aschenbrenner E, Vogl D, Falk W, Gross V . Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut. 2000; 46(3):350-8. PMC: 1727863. DOI: 10.1136/gut.46.3.350. View

3.
Mankertz J, Tavalali S, Schmitz H, Mankertz A, Riecken E, Fromm M . Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci. 2000; 113 ( Pt 11):2085-90. DOI: 10.1242/jcs.113.11.2085. View

4.
Oppmann B, Lesley R, Blom B, Timans J, Xu Y, Hunte B . Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000; 13(5):715-25. DOI: 10.1016/s1074-7613(00)00070-4. View

5.
Pessi T, Sutas Y, Hurme M, Isolauri E . Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy. 2000; 30(12):1804-8. DOI: 10.1046/j.1365-2222.2000.00948.x. View